RhythmAnalytics vs ZEUS System
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is comprehensive, automated interpretation of a wide range of cardiac arrhythmias from various FDA-cleared single-lead ECG devices. This tool is ideal for healthcare professionals seeking detailed, beat-by-beat ECG analysis and clinical decision support that can be integrated via a cloud-based API into existing workflows.
View RhythmAnalytics →Choose ZEUS System if…
Choose the ZEUS System if your focus is on long-term, continuous cardiac monitoring for extended periods, especially for the detection and characterization of Atrial Fibrillation. This system is best suited for remote patient monitoring programs utilizing iRhythm's Zio wearable biosensors, providing preliminary reports for both symptomatic and asymptomatic cardiac events.
View ZEUS System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | ZEUS System |
|---|---|---|
| Pricing | Contact vendor | Not disclosed |
| Deployment | Cloud-based API | Cloud-based (AWS EC2 platform), no on-premise hardware. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS SystemTool B (ZEUS System) offers a more direct and comprehensive user experience for clinicians through its ZioSuite web portal and mobile application, which facilitates patient enrollment, clinical report access, and interpretation. Tool A (RhythmAnalytics) is primarily a cloud-based API designed for integration into other systems, meaning its direct clinical usability depends on third-party development.
Clinical Value
RhythmAnalyticsBoth tools are FDA-cleared and demonstrate strong clinical performance. However, Tool A (RhythmAnalytics) explicitly states detection of 'over 15 types of cardiac arrhythmias' (some sources indicate 'over 30 distinctive cardiac arrhythmias') with detailed beat-by-beat morphology computation, suggesting a broader and more granular diagnostic capability. Clinical evidence for RhythmAnalytics demonstrated cardiologist-level performance with high sensitivity and specificity.
Pricing & Value
ZEUS SystemBoth tools have undisclosed pricing, making a direct cost comparison impossible. However, Tool B (ZEUS System) explicitly states it provides a Business Associate Agreement (BAA), which is a critical component for healthcare organizations to ensure HIPAA compliance and secure handling of Protected Health Information (PHI). This explicit compliance assurance adds significant value and reduces compliance overhead for potential customers.
Enterprise Readiness
ZEUS SystemTool B (ZEUS System) demonstrates stronger enterprise readiness with explicit mentions of HL7-based EHR integration, cloud-based deployment on AWS EC2 with no on-premise hardware, and a Business Associate Agreement (BAA). While Tool A offers a cloud-based API for integration, Tool B provides more specific and comprehensive features for seamless enterprise adoption and workflow integration within a healthcare ecosystem.
Innovation
ZEUS SystemBoth tools are innovative in their application of AI to cardiac care. However, Tool B (ZEUS System) stands out with its integrated approach, combining AI-powered analysis with proprietary, long-term wearable biosensors (Zio Watch and Zio monitors) for continuous monitoring up to 14 days. This comprehensive, end-to-end solution specifically addresses the challenge of detecting and characterizing intermittent cardiac arrhythmias, offering a more complete innovative package.
Support & Docs
ZEUS SystemTool B (ZEUS System) has publicly available 'Instructions for Use' documents for the ZEUS System and associated Zio monitors, and its website indicates dedicated support sections for both patients and healthcare professionals. In contrast, specific documentation and support details for Tool A (RhythmAnalytics) are not as readily apparent from the provided information or web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | ZEUS System |
|---|---|---|
| Name | RhythmAnalytics | ZEUS System |
| Company | Biofourmis Singapore Pte. | iRhythm Technologies |
| Description | FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. | AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. |
| Key Features | AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats); Beat-by-beat morphology computation; ECG signal processing and analysis; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis; Cloud-based API for integration; Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors) | AI-powered arrhythmia detection; Continuous ECG monitoring (up to 14 days); Cloud-based data analytics; Detection and characterization of Atrial Fibrillation (AFib); Preliminary report generation for physicians; Integration with Zio Watch and Zio monitors; Support for symptomatic and asymptomatic cardiac events; HL7-based EHR integration |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and ZEUS System.
Frequently Asked Questions
More Comparisons
More matchups featuring RhythmAnalytics or ZEUS System
Backers
Who funded each tool's parent company.